Professor Vincent Gnanapragasam - Publications

Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial

04 Sep 2021

Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database

03 Feb 2020

Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies of suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study

12 Jun 2020

Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies

09 Jul 2021

Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer

08 Dec 2020

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

16 Jun 2020

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

28 May 2020

Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study

17 Apr 2020

A novel split mode TFBAR device for quantitative measurements of prostate specific antigen in a small sample of whole blood

07 May 2020

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model

12 Mar 2019